Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurogenic Detrusor Overactivity”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)Study completedNCT00224016
What this trial is testing

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Who this might be right for
Detrusor Hyperreflexia
Watson Pharmaceuticals 57
Post-approval studies (Phase 4)Study completedNCT01698138
What this trial is testing

Prevention of Bladder Dysfunction in Acute Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesUrinary Bladder, Overactive
Oslo University Hospital 20
Large-scale testing (Phase 3)Study completedNCT01557244
What this trial is testing

Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 181
Testing effectiveness (Phase 2)WithdrawnNCT00262496
What this trial is testing

Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.

Who this might be right for
Overactive BladderUrinary Incontinence
US Department of Veterans Affairs
Post-approval studies (Phase 4)Study completedNCT01192568
What this trial is testing

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Who this might be right for
Overactive DetrusorNeurogenic Bladder
AbbVie 52
Not applicableLooking for participantsNCT05141487
What this trial is testing

Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder

Who this might be right for
Urinary IncontinenceUrinary Bladder, Neurogenic
VA Office of Research and Development 16
Not applicableStudy completedNCT02138149
What this trial is testing

Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?

Who this might be right for
Spinal Cord InjuryNeurogenic Detrusor OveractivityNeurogenic Lower Urinary Tract Dysfunction
Swiss Paraplegic Research, Nottwil 47
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Not applicableStudy completedNCT02072928
What this trial is testing

Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

Who this might be right for
Urinary Incontinence
Allergan 55
Testing effectiveness (Phase 2)Study completedNCT02676154
What this trial is testing

Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Who this might be right for
Autonomic Dysreflexia
University of British Columbia 15
Large-scale testing (Phase 3)Study completedNCT02501928
What this trial is testing

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 12
Not applicableStudy completedNCT01477736
What this trial is testing

A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity

Who this might be right for
Spinal Cord Injury
Centro de Reabilitação e Readaptação Dr. Henrique Santillo 68
Large-scale testing (Phase 3)Study completedNCT01852045
What this trial is testing

Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

Who this might be right for
Urinary Incontinence
Allergan 114
Not applicableStudy completedNCT05504200
What this trial is testing

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Who this might be right for
Spinal Cord Injuries
RNOH RIC 15
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Not applicableLooking for participantsNCT06515223
What this trial is testing

Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury

Who this might be right for
Spinal Cord InjuriesNeuromodulationNeurogenic Bladder+2 more
University College, London 20
Not applicableStudy completedNCT02010788
What this trial is testing

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

Who this might be right for
Urinary IncontinenceUrinary Bladder, Overactive
Allergan 523
Large-scale testing (Phase 3)UnknownNCT01050114
What this trial is testing

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Who this might be right for
Overactive Bladder
Christopher Patrick Smith 36
Large-scale testing (Phase 3)Looking for participantsNCT05491525
What this trial is testing

Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Who this might be right for
Neurogenic Detrusor Overactivity
Urovant Sciences GmbH 85
Not applicableStudy completedNCT03042052
What this trial is testing

Toxin Retrospective Study

Who this might be right for
Neurogenic Bladder
Centre d'Investigation Clinique et Technologique 805 292
Load More Results